All treatments
Treatment
CYCLOPHOSPHAMIDE MONOHYDRATE clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
HD21 for advanced stages - Treatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphoma; comparison of 4-6 cycles of escalated BEACOPP with 4-6 cycles of BrECADD
This study compares two common treatments for advanced Hodgkin lymphoma (a type of cancer). It looks at how well they work, their side effects, and their impact on quality of life, especially for older patients.
For: Advanced Stage of Hodgkin LymphomaNorway · Austria · Netherlands - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2 Study of Isatuximab in combination with Bortezomib, Cyclophosphamide and Dexamethasone followed by isatuximab and lenalidomide maintenance in Newly Diagnosed Patients with Multiple Myeloma and severe Renal Impairment
This study looks at a new combination of medicines, including isatuximab, for people newly diagnosed with multiple myeloma and kidney problems. Researchers want to see how well these treatments help reduce kidney damage and slow down the myeloma.
For: Newly diagnosed patients with multiple myeloma and severe renal impairmentGreece - AuthorisedPhase I and Phase II (Integrated)- First administration to humans
An adaptive open-label multicentre phase 1/2 trial, to determine the recommended phase 2 dose of CCTx-001, and to assess safety, tolerability, and clinical activity in patients with relapsed/refractory acute myeloid leukaemia (RESOLVE AML 001)
This study is testing a new treatment (CCTx-001) for adults with acute myeloid leukaemia (AML) that has returned or not responded to previous treatments. It aims to find the right dose and check how safe and effective it is.
For: Relapsed/Refractory Acute Myeloid Leukemia (AML)Germany · Spain · Sweden